Assignee
SPROUT PHARMACEUTICALS INC
US15 patents
Top patents by PatentIndex Score
US9730927B2Aug 15, 2017
Use of flibanserin in the treatment of obesity
SPROUT PHARMACEUTICALS INC2 citations72
US9949969B2Apr 24, 2018
Treatment of vasomotor symptoms
SPROUT PHARMACEUTICALS INC3 citations63
US11058683B2Jul 13, 2021
Treating sexual desire disorders with flibanserin
SPROUT PHARMACEUTICALS INC0 citations60
US10166230B2Jan 1, 2019
Treatment of vasomotor symptoms
SPROUT PHARMACEUTICALS INC2 citations60
US9782403B2Oct 10, 2017
Treating sexual desire disorders with flibanserin
SPROUT PHARMACEUTICALS INC1 citations60
US9468639B2Oct 18, 2016
Treating sexual desire disorders with flibanserin
SPROUT PHARMACEUTICALS INC1 citations60
US10874668B2Dec 29, 2020
Use of Flibanserin in the treatment of obesity
SPROUT PHARMACEUTICALS INC0 citations51
US10335407B2Jul 2, 2019
Use of flibanserin in the treatment of obesity
SPROUT PHARMACEUTICALS INC0 citations51
US10675280B2Jun 9, 2020
Treating sexual desire disorders with flibanserin
SPROUT PHARMACEUTICALS INC0 citations50
US10307420B2Jun 4, 2019
Treating sexual desire disorders with flibanserin
SPROUT PHARMACEUTICALS INC0 citations50
US10098876B2Oct 16, 2018
Treating sexual desire disorders with flibanserin
SPROUT PHARMACEUTICALS INC0 citations50
US10004731B2Jun 26, 2018
Flibanserin for the treatment of urinary incontinence and related diseases
SPROUT PHARMACEUTICALS INC0 citations44
US9763936B2Sep 19, 2017
Flibanserin for the treatment of urinary incontinence and related diseases
SPROUT PHARMACEUTICALS INC0 citations44
US10596170B2Mar 24, 2020
Treatment of vasomotor symptoms
SPROUT PHARMACEUTICALS INC0 citations42
US9546141B2Jan 17, 2017
Salts
SPROUT PHARMACEUTICALS INC0 citations34